Early Commercial Director – Vaccines & Immune Therapies

Social network you want to login/join with:

Early Commercial Director – Vaccines & Immune Therapies, Cambridge

col-narrow-left

Client:

Location:

Cambridge, United Kingdom

Job Category:

Other

-

EU work permit required:

Yes

col-narrow-right

Job Reference:

48afb1773dbc

Job Views:

8

Posted:

26.04.2025

Expiry Date:

10.06.2025

col-wide

Job Description:

Join our dynamic and diverse Vaccines and Immune Therapies (V&I) team. Here we draw on our breadth of knowledge and experience, which as a team reflects the diversity of the populations we seek to protect . It’s how we go beyond the usual collaborative models, connecting our thinking, and relationships and partnerships internally and externally. Creating a connected ecosystem and problem-solving in an open, inclusive culture.

We are seeking a strategic commercial professional to effectively partner with our early stage: Candidate Drug Investment Decision (CDID) – Phase 3 viral and bacterial product teams, market affiliates and external partners to shape and build a winning V&I portfolio.

What you will do:

You will help define AZ’s future V&I portfolio by leading the commercial evaluation of early internal and external opportunities and then their integration or externalization . You will be accountable for the strengthening and acceleration of theV&I portfolio (including business development) and developing and implementing ambitious brand and clinical development strategies, operational plans and cases for assets in clinical development up to and including Ph3 ID . You will work cross functionally with colleagues in AZ R&D units to craft the development of the V&I portfolio, ensuring that AZ resource is passionate about the most promising drug candidates.

Key accountabilities:

• Provide strategic commercial input into the product development teams to ensure alignment of asset vision, product strategy, Target Product Profile and clinical development plan
• Setting the commercial strategy and business cases for investment decisions up to and including Phase 3 investment decision.
• Presentation of the commercial strategy to governance bodies ( TA leadership team, Early and Late stage product committees)
• Represent the commercial V&I voice within the global cross functional product team
• Collaborating closely with Business Development functions and coordinating global commercial evaluations of external in-licensing opportunities that could support the TA portfolio strategy
• Engaging with Key External Experts (KEEs) to gather input to inform the Immunology strategy and activities plan including advocacy development
• Continue to drive patient centricity and innovation through all aspects of Early Asset Commercial strategy

Minimum Qualifications:

• Bachelor’s degree is required in Business, Medical or Life sciences
• Significant experience in healthcare or biopharma industry, with experience in the Vaccines area
• Significant and in-depth understanding of global commercial strategy, methodologies and tools (product profiling and positioning, forecasting, pricing and reimbursement, market research techniques, competitive intelligence resources)
• Experience of crafting brand strategy whilst the understanding of product profile was incomplete and evolving
• Detailed ‘hands-on’ knowledge of building TPPs, generating sales forecasts and business cases
• Thorough understanding of the drug development process and the need for commercial line of sight throughout
• Understanding of future healthcare market challenges
• Strong interpersonal and team leadership skills, demonstrating flexibility and a validated ability to deal with complexity under time pressure
• Proven strong influencing skills and stakeholder management
• Experienced and comfortable working in a matrix environment

Preferred Qualifications:

• An advanced degree (MBA, MSc or PhD)
• Significant experience leading commercial evaluation of BD projects

Why AstraZeneca?

We are a changemaker on the world stage at an exciting frontier of medicine. This is backed by deep knowledge and experience in our field. Building on this, we lead the way into the future with energy and drive. We are helping to transform healthcare and build pandemic preparedness to protect against future health crises and to bring lasting immunity to people around the globe. We are committed to our central role in addressing pandemic and endemic diseases and ensuring our products continue to reach and benefit millions of people around the world.

Location: Gaithersburg US or Cambridge UK

Salary: Competitive & Excellent Flexible Employee Benefits Package!

Ready to make a difference? Apply now!

Where can I find out more?

Follow AstraZeneca on LinkedIn

Follow AstraZeneca on Facebook

Follow AstraZeneca on Instagram

#V&I

Date Posted

17-Jun-2024

Join our dynamic and diverse Vaccines and Immune Therapies (V&I) team. Here we draw on our breadth of knowledge and experience, which as a team reflects the diversity of the populations we seek to protect . It’s how we go beyond the usual collaborative models, connecting our thinking, and relationships and partnerships internally and externally. Creating a connected ecosystem and problem-solving in an open, inclusive culture.

We are seeking a strategic commercial professional to effectively partner with our early stage: Candidate Drug Investment Decision (CDID) – Phase 3 viral and bacterial product teams, market affiliates and external partners to shape and build a winning V&I portfolio.

What you will do:

You will help define AZ’s future V&I portfolio by leading the commercial evaluation of early internal and external opportunities and then their integration or externalization . You will be accountable for the strengthening and acceleration of theV&I portfolio (including business development) and developing and implementing ambitious brand and clinical development strategies, operational plans and cases for assets in clinical development up to and including Ph3 ID . You will work cross functionally with colleagues in AZ R&D units to craft the development of the V&I portfolio, ensuring that AZ resource is passionate about the most promising drug candidates.

Key accountabilities:

Provide strategic commercial input into the product development teams to ensure alignment of asset vision, product strategy, Target Product Profile and clinical development plan

Setting the commercial strategy and business cases for investment decisions up to and including Phase 3 investment decision.

Presentation of the commercial strategy to governance bodies ( TA leadership team, Early and Late stage product committees)

Represent the commercial V&I voice within the global cross functional product team

Collaborating closely with Business Development functions and coordinating global commercial evaluations of external in-licensing opportunities that could support the TA portfolio strategy

Engaging with Key External Experts (KEEs) to gather input to inform the Immunology strategy and activities plan including advocacy development

Continue to drive patient centricity and innovation through all aspects of Early Asset Commercial strategy

Minimum Qualifications:

Bachelor’s degree is required in Business, Medical or Life sciences

Significant experience in healthcare or biopharma industry, with experience in the Vaccines area

Significant and in-depth understanding of global commercial strategy, methodologies and tools (product profiling and positioning, forecasting, pricing and reimbursement, market research techniques, competitive intelligence resources)

Experience of crafting brand strategy whilst the understanding of product profile was incomplete and evolving

Detailed ‘hands-on’ knowledge of building TPPs, generating sales forecasts and business cases

Thorough understanding of the drug development process and the need for commercial line of sight throughout

Understanding of future healthcare market challenges

Strong interpersonal and team leadership skills, demonstrating flexibility and a validated ability to deal with complexity under time pressure

Proven strong influencing skills and stakeholder management

Experienced and comfortable working in a matrix environment

Preferred Qualifications:

An advanced degree (MBA, MSc or PhD)

Significant experience leading commercial evaluation of BD projects

Why AstraZeneca?

We are a changemaker on the world stage at an exciting frontier of medicine. This is backed by deep knowledge and experience in our field. Building on this, we lead the way into the future with energy and drive. We are helping to transform healthcare and build pandemic preparedness to protect against future health crises and to bring lasting immunity to people around the globe. We are committed to our central role in addressing pandemic and endemic diseases and ensuring our products continue to reach and benefit millions of people around the world.

Location: Gaithersburg US or Cambridge UK

Salary: Competitive & Excellent Flexible Employee Benefits Package!

Ready to make a difference? Apply now!

Where can I find out more?

Follow AstraZeneca on LinkedIn

Follow AstraZeneca on Facebook

Follow AstraZeneca on Instagram

#V&I

Date Posted

17-Jun-2024

Closing Date

01-Jul-2024Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.